期刊文献+

血清尿酸对冠心病PCI术后凝血及血小板功能的影响 被引量:3

Effects of serum uric acid on the blood coagulation and platelet in the patients with coronary artery disease after PCI
下载PDF
导出
摘要 目的:探讨血清尿酸对冠心病患者行PCI术后凝血及血小板功能的影响。方法:收集2012-06~2015-02来我院救治并行PCI手术的冠心病患者98例,依据血清中尿酸水平将患者分为实验组与对照组,比较两组患者术后的凝血功能及血小板情况。结果:高尿酸血症冠心病并行PCI手术患者的AA%、ADP%、R值及K值均明显低于尿酸正常的患者;而其α角及MA值均明显高于尿酸正常的患者(P<0.05或P<0.01)。结论:高尿酸血症冠心病行PCI术后患者的血小板活性增高,血液处于高凝状态,针对这类患者要做好充分的防治准备。 Objective:To explore the impaction of serum uric acid on the blood coagulation and platelet in the patients with coronary artery disease after PCI.Methods:Ninety-eight cases patients with coronary heart disease who came to our hospital to do PCI were collected from June 2012 to February 2015.All the patients were divided into the experimental group and control group according to the patients' serum uric acid level.And then the blood coagulation and platelet function of the two patients were compared.Results:AA%,ADP%,R value and K value of the patients who had high uric acid hematic disease with coronary artery disease after PCI were significantly lower than the patients with normal uric acid.Theαangle and MA value of the patients who had high uric acid hematic disease with coronary artery disease after PCI were significantly higher than those of the patients with normal uric acid.Conclusion:The platelet activity of patients who had high uric acid hematic disease with coronary artery disease after PCI has increased.And the blood of these patients is in high coagulation state.For such patients should be sufficient to prevent.
作者 张津津 夏云峰 刘润梅 李良 翟红霞 陈海威 李娜 王磊 ZHANG Jinjin XIA Yunfeng LIU Runmei et al(First Department of Cadres, the First Hospital Affiliated to General Hospital of PLA, Beijing 100048,China)
出处 《西北国防医学杂志》 CAS 2017年第2期111-113,共3页 Medical Journal of National Defending Forces in Northwest China
关键词 冠心病 尿酸 凝血 血小板 coronary artery disease uric acid blood coagulation platelet
  • 相关文献

参考文献6

二级参考文献117

  • 1韩雅玲.中国经皮冠状动脉介入治疗指南2012(简本)[J].中国医学前沿杂志(电子版),2012,4(12):50-59. 被引量:133
  • 2Cheung BM, Lain KS. Is intensive LDL-cholesterol lowering beneficial and safe? [J]. Lancet, 2010, 376 (9753): 1622-1624.
  • 3Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent C, Blackwell L, et al. Efficacy and safety of more in- tensive lowering of LDL cholesterol: a recta-analysis of data from 170,000 participants in 26 randomised trials[J]. Lan- cet,2010,376(9753) : 1670-1681.
  • 4Suissa S, Dell'aniello S, Vahey S, et al. Time-window bias in case-control studies: statins and lung cancer[J]. Epidemio- logy,2011,22(2) :228-231.
  • 5Preiss D, Seshasai SR, Welsh P, et al. Risk of incident dia- betes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis [J]. JAMA, 2011, 305 (24): 2556- 2564.
  • 6Patti G, Chello M, Candura D, et al. Randomized trial ot atorvastatin for reduction of post operative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMY DA 3 (Atorvastatin for Reduction of MYocardial Dysrhyth- mia After cardiac surgery) study [ J ]. Circulation,2006,114 (14) : 1455-1461.
  • 7Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreat- ment improves outcomes in patients with acute coronary syn dromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial[J]. J Am Coll Cardiol, 2007, 49(12): 1272-1278.
  • 8Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) Ⅱ trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction[J]. J Am Coil Cardiol, 2009, 54(23): 2157 -2163.
  • 9Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvas-tatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMY- DA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial[J]. J Am Coll Cardiol, 2009, 54(6): 558-565.
  • 10Cannon CP, Braunwald E, Mccabe CH, et al. Intensive ver- sus moderate lipid lowering with statins a{ter acute coronary syndromes[J]. N EnglJ Med, 2004, 350(15): 1495-1504.

共引文献49

同被引文献47

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部